Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins In Healthy Men.

Yuen F, Thirumalai A, Pham C, Swerdloff RS, Anawalt BD, Liu PY, Amory JK, Bremner WJ, Dart C, Wu H, Hull L, Blithe DL, Long J, Wang C, Page ST.

J Clin Endocrinol Metab. 2020 Jan 24. pii: dgaa032. doi: 10.1210/clinem/dgaa032. [Epub ahead of print]

PMID:
31976519
2.

Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.

Anawalt BD, Roth MY, Ceponis J, Surampudi V, Amory JK, Swerdloff RS, Liu PY, Dart C, Bremner WJ, Sitruk-Ware R, Kumar N, Blithe DL, Page ST, Wang C.

Andrology. 2019 Nov;7(6):878-887. doi: 10.1111/andr.12603. Epub 2019 Apr 10.

PMID:
30969032
3.

Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel.

Yuen F, Wu S, Thirumalai A, Swerdloff RS, Page ST, Liu PY, Dart C, Wu H, Blithe DL, Sitruk-Ware R, Long J, Bai F, Hull L, Bremner WJ, Anawalt BD, Wang C.

Andrology. 2019 Mar;7(2):235-243. doi: 10.1111/andr.12577. Epub 2018 Dec 16.

PMID:
30556332
4.

Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations.

Meier-Stephenson V, Bremner WTR, Dalton CS, van Marle G, Coffin CS, Patel TR.

Viruses. 2018 Nov 1;10(11). pii: E603. doi: 10.3390/v10110603.

5.

Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male Pill.

Thirumalai A, Ceponis J, Amory JK, Swerdloff R, Surampudi V, Liu PY, Bremner WJ, Harvey E, Blithe DL, Lee MS, Hull L, Wang C, Page ST.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):423-432. doi: 10.1210/jc.2018-01452.

6.

Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.

Wu S, Yuen F, Swerdloff RS, Pak Y, Thirumalai A, Liu PY, Amory JK, Bai F, Hull L, Blithe DL, Anawalt BD, Parman T, Kim K, Lee MS, Bremner WJ, Page ST, Wang C.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):629-638. doi: 10.1210/jc.2018-01528.

7.

Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive.

Ayoub R, Page ST, Swerdloff RS, Liu PY, Amory JK, Leung A, Hull L, Blithe D, Christy A, Chao JH, Bremner WJ, Wang C.

Andrology. 2017 Mar;5(2):278-285. doi: 10.1111/andr.12303. Epub 2016 Dec 1.

8.

Recognizing Quality Improvement and Patient Safety Activities in Academic Promotion in Departments of Medicine: Innovative Language in Promotion Criteria.

Staiger TO, Mills LM, Wong BM, Levinson W, Bremner WJ, Schleyer AM.

Am J Med. 2016 May;129(5):540-6. doi: 10.1016/j.amjmed.2016.01.006. Epub 2016 Jan 29. No abstract available.

PMID:
26829436
9.

Male hormonal contraception: looking back and moving forward.

Roth MY, Page ST, Bremner WJ.

Andrology. 2016 Jan;4(1):4-12. doi: 10.1111/andr.12110. Epub 2015 Oct 9. Review.

10.

Testicular fine-needle aspiration for the assessment of intratesticular hormone concentrations.

Lee AP, Roth MY, Nya-Ngatchou JJ, Lin K, Walsh TJ, Page ST, Matsumoto AM, Bremner WJ, Amory JK, Anawalt BD.

Asian J Androl. 2016 Jan-Feb;18(1):21-4. doi: 10.4103/1008-682X.156637.

11.

Reproductive endocrinology: Are intramuscular testosterone injections harmful?

Anawalt BD, Bremner WJ.

Nat Rev Endocrinol. 2015 Sep;11(9):510-1. doi: 10.1038/nrendo.2015.111. Epub 2015 Jul 7. No abstract available.

PMID:
26149613
12.

The Clinical Education Partnership Initiative: an innovative approach to global health education.

Monroe-Wise A, Kibore M, Kiarie J, Nduati R, Mburu J, Drake FT, Bremner W, Holmes K, Farquhar C.

BMC Med Educ. 2014 Dec 30;14:1043. doi: 10.1186/s12909-014-0246-5.

13.

Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.

Roth MY, Shih G, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Sitruk-Ware R, Blithe DL, Amory JK.

Contraception. 2014 Oct;90(4):407-12. doi: 10.1016/j.contraception.2014.05.013. Epub 2014 Jun 2.

14.

Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive.

Surampudi P, Page ST, Swerdloff RS, Nya-Ngatchou JJ, Liu PY, Amory JK, Leung A, Hull L, Blithe DL, Woo J, Bremner WJ, Wang C.

Andrology. 2014 Jul;2(4):579-587. doi: 10.1111/j.2047-2927.2014.00216.x. Epub 2014 May 2.

15.

Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.

Roth MY, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Dart C, Sitruk-Ware R, Kumar N, Blithe D, Amory JK.

Andrology. 2013 Nov;1(6):899-905. doi: 10.1111/j.2047-2927.2013.00135.x. Epub 2013 Sep 30.

16.

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

Roth MY, Nya-Ngatchou JJ, Lin K, Page ST, Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Amory JK.

J Clin Endocrinol Metab. 2013 Mar;98(3):1198-206. doi: 10.1210/jc.2012-3527. Epub 2013 Jan 24.

17.

Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

Roth MY, Lin K, Bay K, Amory JK, Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Page ST.

Fertil Steril. 2013 Jan;99(1):132-9. doi: 10.1016/j.fertnstert.2012.09.009. Epub 2012 Oct 3.

18.

Contraception for men: a breakthrough new approach.

Bremner WJ.

Cell. 2012 Aug 17;150(4):667-8. doi: 10.1016/j.cell.2012.07.027.

19.

A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.

Ilani N, Roth MY, Amory JK, Swerdloff RS, Dart C, Page ST, Bremner WJ, Sitruk-Ware R, Kumar N, Blithe DL, Wang C.

J Clin Endocrinol Metab. 2012 Oct;97(10):3476-86. doi: 10.1210/jc.2012-1384. Epub 2012 Jul 12.

20.

Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial.

Mostaghel EA, Lin DW, Amory JK, Wright JL, Marck BT, Nelson PS, Matsumoto AM, Bremner WJ, Page ST.

J Clin Endocrinol Metab. 2012 Aug;97(8):2809-17. doi: 10.1210/jc.2012-1536. Epub 2012 Jun 1.

21.

Pharmacokinetics of modified slow-release oral testosterone over 9 days in normal men with experimental hypogonadism.

Lee A, Rubinow K, Clark RV, Caricofe RB, Bush MA, Zhi H, Roth MY, Page ST, Bremner WJ, Amory JK.

J Androl. 2012 May-Jun;33(3):420-6. doi: 10.2164/jandrol.111.014514. Epub 2011 Aug 25.

22.

The role of quality improvement and patient safety in academic promotion: results of a survey of chairs of departments of internal medicine in North America.

Staiger TO, Wong EY, Schleyer AM, Martin DP, Levinson W, Bremner WJ.

Am J Med. 2011 Mar;124(3):277-80. doi: 10.1016/j.amjmed.2010.09.018. No abstract available.

PMID:
21396513
23.

The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men.

Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Marck B, Bremner WJ, Amory JK.

J Clin Endocrinol Metab. 2011 Apr;96(4):1175-81. doi: 10.1210/jc.2010-2518. Epub 2011 Feb 2.

24.

Testosterone deficiency and replacement in older men.

Bremner WJ.

N Engl J Med. 2010 Jul 8;363(2):189-91. doi: 10.1056/NEJMe1006197. No abstract available.

PMID:
20647215
25.

Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Snyder CN, Marck BT, Bremner WJ, Amory JK.

J Clin Endocrinol Metab. 2010 Aug;95(8):3806-13. doi: 10.1210/jc.2010-0360. Epub 2010 May 19.

26.

Pharmacokinetics of 2 novel formulations of modified-release oral testosterone alone and with finasteride in normal men with experimental hypogonadism.

Snyder CN, Clark RV, Caricofe RB, Bush MA, Roth MY, Page ST, Bremner WJ, Amory JK.

J Androl. 2010 Nov-Dec;31(6):527-35. doi: 10.2164/jandrol.109.009746. Epub 2010 Apr 8.

27.

Serum LH correlates highly with intratesticular steroid levels in normal men.

Roth MY, Lin K, Amory JK, Matsumoto AM, Anawalt BD, Snyder CN, Kalhorn TF, Bremner WJ, Page ST.

J Androl. 2010 Mar-Apr;31(2):138-45. doi: 10.2164/jandrol.109.008391. Epub 2009 Sep 24.

28.

Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics.

Amory JK, Leonard TW, Page ST, O'Toole E, McKenna MJ, Bremner WJ.

Cancer Chemother Pharmacol. 2009 Aug;64(3):641-5. doi: 10.1007/s00280-009-1038-1. Epub 2009 May 29.

29.

Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.

Mahabadi V, Amory JK, Swerdloff RS, Bremner WJ, Page ST, Sitruk-Ware R, Christensen PD, Kumar N, Tsong YY, Blithe D, Wang C.

J Clin Endocrinol Metab. 2009 Jul;94(7):2313-20. doi: 10.1210/jc.2008-2604. Epub 2009 Apr 14.

30.

Immediate post-parathyroidectomy stridor resolved with intravenous calcium.

Adams S, Harold A, Bremner W, Bhatti A.

BMJ Case Rep. 2009;2009. pii: bcr09.2008.0938. doi: 10.1136/bcr.09.2008.0938. Epub 2009 Apr 23.

31.

Long-term outcome studies of testosterone therapy in older hypogonadal men: waiting for Godot?

Matsumoto AM, Bremner WJ.

Nat Clin Pract Endocrinol Metab. 2008 Dec;4(12):645. doi: 10.1038/ncpendmet1002. No abstract available.

PMID:
19020524
32.

Advances in male contraception.

Page ST, Amory JK, Bremner WJ.

Endocr Rev. 2008 Jun;29(4):465-93. doi: 10.1210/er.2007-0041. Epub 2008 Apr 24. Review.

33.

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.

Amory JK, Anawalt BD, Matsumoto AM, Page ST, Bremner WJ, Wang C, Swerdloff RS, Clark RV.

J Urol. 2008 Jun;179(6):2333-8. doi: 10.1016/j.juro.2008.01.145. Epub 2008 Apr 18.

34.

Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.

Liu PY, Swerdloff RS, Anawalt BD, Anderson RA, Bremner WJ, Elliesen J, Gu YQ, Kersemaekers WM, McLachlan RI, Meriggiola MC, Nieschlag E, Sitruk-Ware R, Vogelsong K, Wang XH, Wu FC, Zitzmann M, Handelsman DJ, Wang C.

J Clin Endocrinol Metab. 2008 May;93(5):1774-83. doi: 10.1210/jc.2007-2768. Epub 2008 Feb 26.

35.
36.

Nanomilled oral testosterone plus dutasteride effectively normalizes serum testosterone in normal men with induced hypogonadism.

Page ST, Bremner WJ, Clark RV, Bush MA, Zhi H, Caricofe RB, Smith PM, Amory JK.

J Androl. 2008 Mar-Apr;29(2):222-7. Epub 2007 Dec 12.

37.
38.

Sex steroids and all-cause and cause-specific mortality in men.

Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB.

Arch Intern Med. 2007 Jun 25;167(12):1252-60.

PMID:
17592098
39.

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM, Bremner WJ, Gleave ME, Nelson PS.

Cancer Res. 2007 May 15;67(10):5033-41.

40.

Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.

Page ST, Kalhorn TF, Bremner WJ, Anawalt BD, Matsumoto AM, Amory JK.

J Androl. 2007 Sep-Oct;28(5):734-41. Epub 2007 May 9.

41.
42.

Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception.

Amory JK, Page ST, Anawalt BD, Coviello AD, Matsumoto AM, Bremner WJ.

J Androl. 2007 Jul-Aug;28(4):548-54. Epub 2007 Feb 21.

43.

Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.

Amory JK, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ.

Contraception. 2007 Mar;75(3):218-23. Epub 2007 Jan 16.

PMID:
17303493
44.

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.

Amory JK, Wang C, Swerdloff RS, Anawalt BD, Matsumoto AM, Bremner WJ, Walker SE, Haberer LJ, Clark RV.

J Clin Endocrinol Metab. 2007 May;92(5):1659-65. Epub 2007 Feb 13. Erratum in: J Clin Endocrinol Metab. 2007 Nov;92(11):4379.

PMID:
17299062
45.

DHEA and testosterone in the elderly.

Page ST, Matsumoto AM, Bremner WJ.

N Engl J Med. 2007 Feb 8;356(6):635; author reply 637. No abstract available.

PMID:
17287487
46.

Multicomponent reactions to form heterocycles by microwave-assisted continuous flow organic synthesis.

Bremner WS, Organ MG.

J Comb Chem. 2007 Jan-Feb;9(1):14-6. No abstract available.

PMID:
17206827
47.

10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception.

Aaltonen P, Amory JK, Anderson RA, Behre HM, Bialy G, Blithe D, Bone W, Bremner WJ, Colvard D, Cooper TG, Elliesen J, Gabelnick HL, Gu YQ, Handelsman DJ, Johansson EA, Kersemaekers W, Liu P, MacKay T, Matlin S, Mbizvo M, McLachlan RI, Meriggiola MC, Mletzko S, Mommers E, Muermans H, Nieschlag E, Odlind V, Page ST, Radlmaier A, Sitruk-Ware R, Swerdloff R, Wang C, Wu F, Zitzmann M.

J Androl. 2007 May-Jun;28(3):362-3. Epub 2006 Dec 27. No abstract available.

48.

Miglustat has no apparent effect on spermatogenesis in normal men.

Amory JK, Muller CH, Page ST, Leifke E, Pagel ER, Bhandari A, Subramanyam B, Bone W, Radlmaier A, Bremner WJ.

Hum Reprod. 2007 Mar;22(3):702-7. Epub 2006 Oct 25.

PMID:
17067996
49.

Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.

Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ.

J Clin Endocrinol Metab. 2006 Nov;91(11):4374-80. Epub 2006 Aug 29.

PMID:
16940442
50.

Drug insight: Recent advances in male hormonal contraception.

Amory JK, Page ST, Bremner WJ.

Nat Clin Pract Endocrinol Metab. 2006 Jan;2(1):32-41. Review.

PMID:
16932251

Supplemental Content

Loading ...
Support Center